Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively ...
In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...
emjreviews.com2 天
New COPD Drug Cuts Healthcare Burden
A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...